ExpreS2ion Biotech Stock Forward View - Accumulation Distribution
| EXPRS2 Stock | SEK 15.22 0.32 2.15% |
ExpreS2ion Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast ExpreS2ion Biotech stock prices and determine the direction of ExpreS2ion Biotech Holding's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of ExpreS2ion Biotech's historical fundamentals, such as revenue growth or operating cash flow patterns.
The value of RSI of ExpreS2ion Biotech's share price is above 70 at this time suggesting that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling ExpreS2ion, making its price go up or down. Momentum 70
Buy Stretched
Oversold | Overbought |
Using ExpreS2ion Biotech hype-based prediction, you can estimate the value of ExpreS2ion Biotech Holding from the perspective of ExpreS2ion Biotech response to recently generated media hype and the effects of current headlines on its competitors.
ExpreS2ion Biotech after-hype prediction price | SEK 15.22 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
ExpreS2ion |
ExpreS2ion Biotech Additional Predictive Modules
Most predictive techniques to examine ExpreS2ion price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ExpreS2ion using various technical indicators. When you analyze ExpreS2ion charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 331.01 | 0.0624 |
| Check ExpreS2ion Biotech Volatility | Backtest ExpreS2ion Biotech | Information Ratio |
ExpreS2ion Biotech Trading Date Momentum
| On March 02 2026 ExpreS2ion Biotech Holding was traded for 15.22 at the closing time. The highest price during the trading period was 15.38 and the lowest recorded bid was listed for 14.42 . There was no trading activity during the period 0.0. Lack of trading volume on March 2, 2026 did not affect price variability. The overall trading delta to the current price is 1.97% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare ExpreS2ion Biotech to competition |
Other Forecasting Options for ExpreS2ion Biotech
For every potential investor in ExpreS2ion, whether a beginner or expert, ExpreS2ion Biotech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. ExpreS2ion Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in ExpreS2ion. Basic forecasting techniques help filter out the noise by identifying ExpreS2ion Biotech's price trends.ExpreS2ion Biotech Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ExpreS2ion Biotech stock to make a market-neutral strategy. Peer analysis of ExpreS2ion Biotech could also be used in its relative valuation, which is a method of valuing ExpreS2ion Biotech by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
ExpreS2ion Biotech Market Strength Events
Market strength indicators help investors to evaluate how ExpreS2ion Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ExpreS2ion Biotech shares will generate the highest return on investment. By undertsting and applying ExpreS2ion Biotech stock market strength indicators, traders can identify ExpreS2ion Biotech Holding entry and exit signals to maximize returns.
ExpreS2ion Biotech Risk Indicators
The analysis of ExpreS2ion Biotech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in ExpreS2ion Biotech's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting expres2ion stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.6 | |||
| Standard Deviation | 3.8 | |||
| Variance | 14.45 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for ExpreS2ion Biotech
The number of cover stories for ExpreS2ion Biotech depends on current market conditions and ExpreS2ion Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that ExpreS2ion Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about ExpreS2ion Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
ExpreS2ion Biotech Short Properties
ExpreS2ion Biotech's future price predictability will typically decrease when ExpreS2ion Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of ExpreS2ion Biotech Holding often depends not only on the future outlook of the potential ExpreS2ion Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. ExpreS2ion Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 32.9 M | |
| Cash And Short Term Investments | 138.9 M |
Other Information on Investing in ExpreS2ion Stock
ExpreS2ion Biotech financial ratios help investors to determine whether ExpreS2ion Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ExpreS2ion with respect to the benefits of owning ExpreS2ion Biotech security.